Source link : https://www.newshealth.biz/health-news/does-stopping-ici-therapy-affect-survival-in-hnscc/
TOPLINE: Patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) treated with immune checkpoint inhibitors (ICIs) show comparable survival outcomes whether they continued or discontinued treatment at 1 or 2 years vs continued past those points. METHODOLOGY: Although ICIs are a frontline treatment for patients with recurrent or metastatic HNSCC, questions remain […]
Author : News Health
Publish date : 2024-09-04 10:29:45
Copyright for syndicated content belongs to the linked Source.